HighMark Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.59M Buy
1,728
+8
+0.5% +$8.11K 0.65% 24
2025
Q4
$1.85M Buy
1,720
+2
+0.1% +$1.91K 0.75% 19
2025
Q3
$1.31M Hold
1,718
0.58% 23
2025
Q2
$1.34M Sell
1,718
-7
-0.4% -$5.44K 0.65% 21
2025
Q1
$1.42M Sell
1,725
-37
-2% -$30.8K 0.84% 17
2024
Q4
$1.36M Sell
1,762
-476
-21% -$394K 0.78% 17
2024
Q3
$1.98M Buy
2,238
+23
+1% +$20.7K 1.09% 13
2024
Q2
$2.01M Buy
2,215
+7
+0.3% +$5.6K 1.21% 10
2024
Q1
$1.72M Buy
2,208
+193
+10% +$137K 1.07% 10
2023
Q4
$1.17M Hold
2,015
0.87% 11
2023
Q3
$1.08M Sell
2,015
-28
-1% -$14.4K 0.9% 14
2023
Q2
$958K Hold
2,043
0.72% 20
2023
Q1
$702K Buy
2,043
+23
+1% +$7.76K 0.55% 25
2022
Q4
$739K Buy
2,020
+2
+0.1% +$709 0.56% 24
2022
Q3
$652K Hold
2,018
0.56% 20
2022
Q2
$654K Hold
2,018
0.53% 22
2022
Q1
$578K Buy
2,018
+16
+0.8% +$4.12K 0.39% 23
2021
Q4
$553K Hold
2,002
0.35% 29
2021
Q3
$462K Hold
2,002
0.34% 31
2021
Q2
$459K Hold
2,002
0.34% 30
2021
Q1
$374K Hold
2,002
0.3% 33
2020
Q4
$338K Buy
2,002
+10
+0.5% +$1.49K 0.29% 30
2020
Q3
$295K Buy
1,992
+10
+0.5% +$1.55K 0.27% 33
2020
Q2
$325K Buy
1,982
+10
+0.5% +$1.53K 0.36% 27
2020
Q1
$273K Buy
1,972
+11
+0.6% +$1.51K 0.33% 23
2019
Q4
$257K Buy
+1,961
New +$227K 0.27% 29

Other funds holding LLY

HighMark Wealth Management's LLY Position: Q1 2026 in Review

HighMark Wealth Management increased its Eli Lilly (LLY) stake by 0.47% in Q1 2026, buying an estimated $8.11K and bringing the position to 1,728 shares worth $1.59M. The position accounts for 0.65% of the portfolio, ranked #24.

HighMark Wealth Management first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.01M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • HighMark Wealth Management held 1,728 shares of Eli Lilly worth $1.59M as of Q1 2026.
  • HighMark Wealth Management bought 8 Eli Lilly shares in Q1 2026, an estimated $8.11K.
  • Eli Lilly made up 0.65% of HighMark Wealth Management's portfolio in Q1 2026, its #24 holding.
  • HighMark Wealth Management first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
  • HighMark Wealth Management's Eli Lilly position peaked at $2.01M in Q2 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on HighMark Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.